Outcome according to subspecies following lung transplantation in cystic fibrosis pediatric patients infected with Mycobacterium abscessus

Transpl Infect Dis. 2020 Jun;22(3):e13274. doi: 10.1111/tid.13274. Epub 2020 Mar 18.

Abstract

Background: Mycobacterium abscessus infection has been associated with variable outcomes following lung transplantation. M abscessus comprises three subspecies (M abscessus subsp abscessus, M abscessus subsp massiliense, and M abscessus subsp bolletii). We investigated whether lung transplantation outcome in cystic fibrosis (CF) patients in a single center was related to the M abscessus subspecies and genetic cluster.

Methods: CF patients with chronic M abscessus infection transplanted at Great Ormond Street Hospital between 2004 and 2017 were retrospectively examined. All M abscessus isolates were identified to subspecies level by polymerase chain reaction and sequencing. Genetic cluster was determined by variable number tandem repeat profiling and whole-genome sequencing (WGS), and sequence type inferred from WGS.

Results: Thirteen patients with chronic M abscessus infection underwent heart/lung or lung transplantation. Subspecies identification showed n = 1 with M abscessus bolletii, n = 5 with M abscessus massiliense, and n = 7 with M abscessus abscessus infection. Eight (62%) patients (one with M abscessus massiliense and seven with M abscessus abscessus) died post-lung transplant. The patient with M abscessus bolletii and three patients with M abscessus massiliense did well post-transplant. One patient with M abscessus massiliense is receiving ongoing treatment.

Conclusions: Dramatically worse outcomes are observed in patients infected with M abscessus subspecies abscessus, the majority of whom were infected with ST-1 and ST-26 strains. Patients infected with other M abcsessus strains can have acceptable outcomes.

Keywords: Mycobacterium abscessus; cystic fibrosis; non-tuberculous mycobacterium; pediatric lung transplantation.

MeSH terms

  • Adolescent
  • Child
  • Cystic Fibrosis / complications*
  • Cystic Fibrosis / microbiology
  • Cystic Fibrosis / surgery
  • DNA, Bacterial / genetics
  • Female
  • Humans
  • Lung Transplantation / adverse effects*
  • Male
  • Microbial Sensitivity Tests
  • Mycobacterium Infections, Nontuberculous / microbiology*
  • Mycobacterium Infections, Nontuberculous / physiopathology
  • Mycobacterium abscessus / classification*
  • Mycobacterium abscessus / pathogenicity
  • Outcome and Process Assessment, Health Care
  • Phylogeny
  • Retrospective Studies
  • Sequence Analysis, DNA
  • Whole Genome Sequencing

Substances

  • DNA, Bacterial